Recent Updates
Recently added Catalysts
CHRS Positive Sentiment

Coherus BioSciences to Present at Upcoming Investor Conferences in May

Thursday, May 4, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Coherus BioSciences, Inc. announced participation in two key investor conferences in May. The first event is the Bank of America Merrill Lynch Global Healthcare 2023 Conference in Las Vegas on May 11, followed by the UBS Global Healthcare Conference at UBS headquarters on May 23. The company will hold a fireside chat at the first conference and 1x1 meetings at the second. An audio webcast of the fireside chat will be available for interested parties.
Price reaction · baseline $7.3 (2023-05-03 close) · hit after-hours · 1 other CHRS headline(s) in the window, move may be shared
day 0 close
+0.3%

Conference Participation Details

UBS Global Healthcare Conference
Date: November 11, 2025
Time: 8:45 a.m. ET
Format: Fireside Chat

How to Access

Investors and the general public can listen to both sessions live at:

https://investor.viatris.com

Archived versions will be available following the live events for a limited time.

Market Sentiment Analysis

POSITIVE FACTORS

  • Coherus BioSciences will be participating in prominent investor conferences.
  • The company will engage with potential investors, enhancing visibility.
  • An audio webcast of the fireside chat will be accessible for broader audience engagement.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+136%
120-day peak, hindsight
Typical move
6.6%
average across 12 past catalysts
Cash runway
~5 mo
High dilution risk
Lead asset
CHS-0214
Phase 3 · Rheumatoid Arthritis

Full Press Release Details

REDWOOD CITY, Calif., May 04, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus“, Nasdaq: CHRS) today announced that senior management will participate in the following investor conferences:
Bank of America Merrill Lynch Global Healthcare 2023 Conference in Las Vegas on Thursday, May 11, 2023; fireside chat at 10:15 a.m. PDT
UBS Global Healthcare Conference at UBS NY headquarters on Tuesday, May 23, 2023 for 1x1 meetings only between 8:00 a.m. and 5:00 p.m. EDT
An audio webcast of the fireside chat presentation will be available on the investors’ page of the Coherus website at http://investors.coherus.com. Please access the website prior to the start of the presentation to ensure a timely connection to the webcast. The webcast will be archived on the Coherus website for 30 days.
Coherus Contact Information:

Frequently Asked Questions

When is Coherus participating in the Bank of America conference?

Coherus will participate on May 11, 2023, at 10:15 a.m. PDT.

What type of meetings will Coherus have on May 23, 2023?

Coherus will have 1x1 meetings only at the UBS Global Healthcare Conference.

Where can I listen to the Coherus fireside chat?

The fireside chat audio webcast is available on Coherus' investors page.

How long will the webcast be available on the Coherus website?

The webcast will be archived for 30 days on the Coherus website.

Who is the contact for Coherus investor relations?

Marek Ciszewski is the SVP of Investor Relations at Coherus.

ShareAdd on Google
Tags: CHRS Viatris Investor Conferences Healthcare Coherus BioSciences investor conferences healthcare fireside chat
Last updated: May 4, 2023

Conference Timeline

Nov 11, 2025
UBS Global Healthcare Conference
8:45 AM ET • Fireside Chat
Nov 18, 2025
Jefferies Global Healthcare
11:30 AM GMT • London

Biotech snapshot

Cash runway
$105M liquidity · $21M/mo burn
~5 mo
High dilution risk
Lead asset
CHS-0214Phase 3
Rheumatoid Arthritis →

Catalyst track record

+136%
best trade around CHRS's most recent catalyst

Peak hindsight return over a 120-day window, across 12 tracked FDA/PDUFA catalysts for CHRS.

See every catalyst's timing & PoA →